Defunct Company
Total Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
126,661
NCT02678754
Caris Molecular Intelligence Registry
Phase: N/A
Role: Lead Sponsor
Start: Feb 28, 2010
Completion: Nov 1, 2019
NCT01499394
Caris Biorepository Research Protocol
Start: Nov 30, 2010
Completion: Nov 30, 2025
NCT01499381
EMBRACE1: Prostate Biorepository
Start: Dec 31, 2011
Completion: Jul 31, 2012
NCT03326479
POA Retrospective Repository
Start: Nov 30, 2016
Completion: Jan 1, 2023
NCT03324841
POA Prospective Repository
Start: Jun 7, 2017
NCT03937544
Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL
Phase: Phase 2/3
Role: Collaborator
Start: Mar 19, 2019
Completion: Mar 18, 2027
NCT06851949
Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure
Phase: Phase 2
Start: Nov 15, 2024
Completion: Apr 30, 2031
NCT07160075
HIV Prevention With PrEP Among People on Opioid Replacement Therapy
Phase: Phase 4
Start: Aug 28, 2025
Completion: Sep 1, 2027
NCT06002386
Vsling™ III: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients with Heart Failure
Start: Aug 31, 2025
Completion: Dec 31, 2029